Trials / Completed
CompletedNCT03141450
Plasma Concentrations of Prophylactic Cefazolin in Pediatric Patients Undergoing Cardiac Surgery With CPB
Plasma Concentrations of Prophylactic Cefazolin in Pediatric Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (actual)
- Sponsor
- Mahidol University · Academic / Other
- Sex
- All
- Age
- 7 Years
- Healthy volunteers
- Not accepted
Summary
Surgical site infection (SSI) is a serious operative complication that may be associated with any surgical procedures. It increases morbidity and mortality after cardiac surgery. Plasma concentration of prophylactic antibiotic, routinely cefazolin, is altered by effects of cardiopulmonary bypass. This study is conducted to measure the plasma concentrations of cefazolin to determine its adequacy in pediatric patients undergoing elective cardiac surgery with cardiopulmonary bypass including its correlation with the incidence of postoperative SSI.
Conditions
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2017-05-05
- Last updated
- 2020-04-06
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT03141450. Inclusion in this directory is not an endorsement.